“Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population”. Journal of Pharmaceutical Negative Results, Oct. 2022, pp. 209-12, https://doi.org/10.47750/pnr.2022.13.S02.29.